Does PEMBROLIZUMAB Cause Dermatitis? 228 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 228 reports of Dermatitis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.3% of all adverse event reports for PEMBROLIZUMAB.
228
Reports of Dermatitis with PEMBROLIZUMAB
0.3%
of all PEMBROLIZUMAB reports
23
Deaths
75
Hospitalizations
How Dangerous Is Dermatitis From PEMBROLIZUMAB?
Of the 228 reports, 23 (10.1%) resulted in death, 75 (32.9%) required hospitalization, and 10 (4.4%) were considered life-threatening.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
SECUKINUMAB (294)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
Which PEMBROLIZUMAB Alternatives Have Lower Dermatitis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G